Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelvic lymph node metastases imaging with Sinerem in bladder and prostate cancer
2004-004567-29Phase 3Completed
- Sponsor
- Innovative Sensor Technology IST AG
- Start
- Feb 2007
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ferumoxtran-10 in bladder cancer, prostate cancer (PCa) and metastatic malignant neoplasm in lymph node (LNM), sponsored by Innovative Sensor Technology IST AG. Primary endpoint: Diagnostic accuracy of Sinerem-enhanced MRI for pelvic lymph node metastases. Started Feb 2007; status: completed.
02
Drugs
ferumoxtran-10
03
Conditions
bladder cancerprostate cancer (PCa)metastatic malignant neoplasm in lymph node (LNM)
Beyond the preview
Go deeper on 2004-004567-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004567-29.